Rat PK for the DYT1 lead compound

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026Q00987

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

Q301

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a solicitation (Procurement Identifier: 75N98026Q00987) for the procurement of a "Rat PK for the DYT1 lead compound." This opportunity is presented as a combined synopsis/solicitation for commercial items, in accordance with FAR Subpart 12.6, and is intended to result in a firm-fixed-price contract or purchase order. The procurement is being conducted under the streamlined procedures of FAR 12.603, with the expectation that the total value will not exceed the simplified acquisition threshold. The primary objective of this procurement is to obtain pharmacokinetic (PK) studies in rats for a lead compound associated with DYT1, which is likely related to research in the life sciences field. The intended outcome is to generate data that will inform further development or evaluation of the DYT1 lead compound, supporting NIH’s ongoing research initiatives. Key requirements and deliverables for this solicitation include the provision of commercial products or services that meet the specifications for conducting rat PK studies. Offerors are expected to demonstrate their capability to perform research and development activities in the physical, engineering, and life sciences, excluding nanotechnology and biotechnology, as indicated by the associated NAICS code 541715. The Product Service Code (PSC) for this requirement is Q301, which pertains to medical- laboratory testing. This solicitation is unrestricted, allowing for full and open competition. There are no set-aside requirements for small businesses or other socioeconomic categories. The applicable NAICS code, 541715, carries a small business size standard of 1,000 employees, but all qualified entities are encouraged to submit proposals. The contracting entity for this opportunity is the National Institutes of Health OLAO, a federal office under the Department of Health and Human Services. The primary point of contact for this solicitation is Jaddua C. Johnston, who can be reached via email at [email protected]. Interested parties should note that the solicitation and all incorporated provisions and clauses are current as of the Federal Acquisition Circular effective August 7, 2026. The solicitation was posted on August 18, 2026, with a response deadline of August 24, 2026. All relevant documentation and attachments are available through the official SAM.gov opportunity listing (Opportunity ID: 5a83f185face47bca03e1e96e51f6622). Contractors considering this opportunity should ensure they have the requisite experience and capacity to conduct pharmacokinetic studies in laboratory animals, particularly rats, and are able to comply with all applicable federal acquisition regulations and NIH requirements. This procurement represents a valuable opportunity for organizations specializing in preclinical research and laboratory testing services to support NIH’s mission in advancing scientific knowledge and medical research.